Selected article for: "risk factor and SARS case"
Author: Pikovsky, Margaret; Tan, Min Yi; Ahmed, Amanda; Sykes, Lynne; Agha-Jaffar, Rochan; Yu, Christina K. H.
Title: Euglycaemic ketoacidosis in pregnant women with COVID-19: two case reports
  • Cord-id: of2hicyg
  • Document date: 2021_6_16
    • ID: of2hicyg
    Snippet: BACKGROUND: Euglycaemic ketoacidosis (EKA) is an infrequent but serious condition which usually follows a period of starvation, severe vomiting or illness in individuals with or without diabetes. Ketoacidosis is associated with materno-fetal morbidity and mortality necessitating prompt diagnosis and management. Physiological increases in insulin resistance render pregnancy a diabetogenic state with increased susceptibility to ketosis. COVID-19 is associated with worse clinical outcomes in patien
    Document: BACKGROUND: Euglycaemic ketoacidosis (EKA) is an infrequent but serious condition which usually follows a period of starvation, severe vomiting or illness in individuals with or without diabetes. Ketoacidosis is associated with materno-fetal morbidity and mortality necessitating prompt diagnosis and management. Physiological increases in insulin resistance render pregnancy a diabetogenic state with increased susceptibility to ketosis. COVID-19 is associated with worse clinical outcomes in patients with diabetes and is an independent risk factor for ketoacidosis in normoglycaemic individuals. CASE PRESENTATIONS: We describe two cases of SARS-CoV-2 positive pregnant women presenting with normoglycaemic metabolic ketoacidosis. Both cases were associated with maternal and fetal compromise, requiring aggressive fluid and insulin resuscitation and early delivery. CONCLUSION: We discuss possible physiology and propose a management strategy for euglycaemic ketoacidosis in pregnancy.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and additional challenge: 1, 2
    • acute ards respiratory distress syndrome and admission prior: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and lung change: 1, 2, 3
    • acute ards respiratory distress syndrome and lung parenchyma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • admission prior and low molecular weight: 1, 2
    • admission prior and low molecular weight heparin: 1, 2
    • low molecular weight and lung parenchyma: 1, 2, 3
    • low molecular weight heparin and lung parenchyma: 1, 2